| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |